logo
U.S. tariffs will be test of luxury brands' pricing power

U.S. tariffs will be test of luxury brands' pricing power

CTV News5 days ago
PARIS/NEW YORK — Luxury goods companies were spared their worst case scenario in Sunday's EU-U.S. trade deal but they face a delicate balancing act as already weak consumer demand tests their ability to raise prices further.
Big labels like Chanel and LVMH's Louis Vuitton and Dior have relied on dramatic price increases in recent years to drive a chunk of their profit growth.
Jacques Roizen, managing director, China, at Digital Luxury Group, said the deal struck by U.S. President Donald Trump and European Commission President Ursula von der Leyen on Sunday, imposing a 15 per cent tariff on EU goods, brings much needed certainty to luxury's key U.S. market.
Yet, 'brands are treading carefully with further price hikes to avoid alienating younger and occasional shoppers,' he said.
Although baseline duties are below a hefty 30 per cent levy that Trump had threatened just a couple of weeks ago, they are a far cry from the zero-for-zero tariff deal Brussels was hoping to clinch.
Fresh tariffs also come as the luxury goods industry is counting on the U.S. as former growth engine China sputters and sales globally are in decline.
'Tariffs are definitely going to affect my buying behavior, depending on the rate of the tariff. I would think twice before I just pick things up,' said Abida Taher, a 53-year-old physician who was out shopping at Saks Fifth Avenue in New York City last week and likes Valentino among other Italian and French brands.
Bernard Arnault, chairman and CEO of French luxury giant LVMH, embarked on an intense lobbying campaign with EU leaders to ease tensions with the Trump administration and last week announced plans for a new Louis Vuitton factory in Texas.
Such a move, however, would be too complicated and costly for most European brands - involving the transfer of local skills that take years to build up, industry experts caution.
Some high end labels say they will be able to draw on pricing power to offset the cost of tariffs, but analysts and industry practitioners warn some players have limited wiggle room after a series of outsized price tag hikes.
Big luxury companies profited from a rebound of consumer demand after the pandemic, hiking prices by 33 per cent on average between 2019 and 2023, according to RBC estimates.
The price tag of Chanel's classic quilted flap bag more than tripled between 2015 and 2024, while the Lady Dior bag and Louis Vuitton Keepall travel bag more than doubled, according to UBS analysts.
Luxury disconnect
Half of the luxury industry's sales growth came from price hikes in the four years from 2019, compared to a third between 2016 and 2023, UBS analysts said.
Yet the sector lost 50 million customers last year, according to consultancy Bain, as economic pressures and price fatigue dampened appetite for designer clothing and handbags.
Brands that got the pricing balance wrong are the ones struggling more today, said Flavio Cereda, who manages GAM's Luxury Brands investment strategy.
'The significant deceleration in momentum, uneven as it was, is a natural consequence of a period of excess,' said Cereda.
Hermes HRMS.PA, which notably held back on large price increases during the post pandemic boom, has outpaced rivals and analysts forecast a 10 per cent rise in second quarter sales when it reports on Wednesday.
UBS estimates that a 15 per cent tariff on exports to the United States will require luxury brands on average to raise prices by around two per cent in the United States, or around one per cent globally if they want to avoid widening regional price gaps – or face an impact of around three per cent on earnings before interest and tax.
Such hikes may prove challenging while the latest round of luxury players' earnings shows little sign of a rebound.
LVMH's second quarter sales missed expectations, weighed down by weakening sales at flagship brands Louis Vuitton and Dior, while outerwear specialist Moncler's sales contracted by one per cent and Kering-owned Gucci is expected to continue to struggle.
Caroline Reyl, head of premium brands at Pictet Asset Management, said there has been a 'disconnect' between the prices of certain luxury items and their perceived quality and creativity in the past four years.
Precious Buckner, a 37-year old clinical therapist from North Carolina, was looking at a Chanel classic flap bag at Saks Fifth Avenue in Manhattan last week but said if it goes up in price because of tariffs it would no longer be worth it.
'I'm going to these stores to see the size, the fit, how I like it, so I can get it on resale,' Buckner said, noting she would be willing to pay $8,000 for a bag on a resale platform like The RealReal or Fashionphile rather than pay $12,000 in a department store.
Bain forecasts worldwide luxury goods sales will fall by between two per cent and five per cent in 2025 after a one per cent decline last year, the biggest contraction in 15 years excluding COVID.
To counter the downtrend, the industry has embarked on a recruitment drive, with new designers at Chanel, Gucci, LVMH labels Dior, Celine, Givenchy and Loewe, and Versace.
Yet, renewing styles to find a better alignment between prices and product value will take time.
'You can't snap your fingers and do it in a couple of weeks,' said Reyl.
(Reporting by Mimosa Spencer and Sami Marshak; Editing by Lisa Jucca and Susan Fenton)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Paramount Global Reports Strong Q2 2025 Earnings
Paramount Global Reports Strong Q2 2025 Earnings

Globe and Mail

time7 minutes ago

  • Globe and Mail

Paramount Global Reports Strong Q2 2025 Earnings

Paramount Global ( (PARA)) has released its Q2 earnings. Here is a breakdown of the information Paramount Global presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Paramount Global is a leading global media and entertainment company known for its extensive portfolio of iconic brands, including CBS, Paramount Pictures, and Paramount+, offering a wide range of content and streaming services. In its latest earnings report for Q2 2025, Paramount Global highlighted its continued transformation into a streaming-first company, with direct-to-consumer (DTC) revenue growing by 15% year-over-year, driven by the strong performance of Paramount+. The company's total revenue increased by 1% compared to the previous year, with notable growth in affiliate and subscription revenue. Paramount+ saw a 23% increase in total revenue and a 24% rise in subscription revenue, reflecting improved watch time and reduced churn. Despite a 6% decline in TV media revenue, the company achieved significant milestones in its content offerings, with CBS maintaining its position as the most-watched broadcast network in primetime for the 17th consecutive season. Paramount Pictures also reported a successful quarter, with the global premiere of 'Mission: Impossible – The Final Reckoning' setting a franchise record for the biggest global opening. Looking ahead, Paramount Global's management remains optimistic about the company's growth prospects, emphasizing the strength of its content strategy and the ongoing expansion of its streaming services.

Comcast Reports Strong Q2 2025 Earnings Growth
Comcast Reports Strong Q2 2025 Earnings Growth

Globe and Mail

timean hour ago

  • Globe and Mail

Comcast Reports Strong Q2 2025 Earnings Growth

Comcast Corp ( (CMCSA)) has released its Q2 earnings. Here is a breakdown of the information Comcast Corp presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Comcast Corporation is a global media and technology company that provides broadband, wireless, and video services through brands like Xfinity and Sky, and produces and distributes content via NBC, Universal, and Peacock, among others. In its second-quarter earnings report for 2025, Comcast Corporation announced a 2.1% increase in revenue to $30.3 billion and a significant rise in net income attributable to Comcast to $11.1 billion, largely due to a $9.4 billion gain from the sale of its interest in Hulu. The company also reported a 3.3% increase in adjusted earnings per share to $1.25 and generated $4.5 billion in free cash flow. Comcast's wireless business achieved record growth, adding 378,000 lines, and its theme parks segment saw a revenue increase of 18.9%, driven by the opening of Epic Universe. The company's media segment also performed well, with Peacock revenue up 18%. Despite a decrease in adjusted net income by 1.7%, Comcast returned $2.9 billion to shareholders through dividends and share repurchases. Looking ahead, Comcast remains confident in its strategic focus and capital allocation, positioning itself well for future growth with plans to expand its content offerings, including NBA coverage on Peacock.

AbbVie Reports Strong Q2 2025 Financial Results
AbbVie Reports Strong Q2 2025 Financial Results

Globe and Mail

timean hour ago

  • Globe and Mail

AbbVie Reports Strong Q2 2025 Financial Results

Abbvie ( (ABBV)) has released its Q2 earnings. Here is a breakdown of the information Abbvie presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie Inc. is a global biopharmaceutical company that focuses on discovering and delivering innovative medicines in key therapeutic areas such as immunology, neuroscience, oncology, and eye care, alongside its Allergan Aesthetics portfolio. In the second quarter of 2025, AbbVie reported a strong financial performance with an increase in net revenues and adjusted earnings per share, highlighting the company's diversified growth platform and strategic investments in innovation. Key financial metrics from the quarter include a 6.6% increase in net revenues to $15.423 billion, driven by significant growth in the immunology and neuroscience portfolios. Skyrizi and Rinvoq showed substantial revenue increases of 62.2% and 41.8%, respectively, while the neuroscience portfolio grew by 24.2%. However, the aesthetics portfolio saw a decline of 8.1% in revenues. AbbVie also announced several strategic advancements, including FDA approvals for new treatments and positive clinical trial results, which bolster its pipeline and future growth prospects. The company has raised its full-year 2025 adjusted diluted EPS guidance, reflecting confidence in continued momentum. Looking ahead, AbbVie remains optimistic about its growth trajectory, supported by its robust pipeline and strategic initiatives, as it continues to focus on delivering innovative solutions to address significant health challenges.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store